Poynard, T <br/><br/>
Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group.  [electronic resource] 

 -  The New England journal of medicine  May 1991 
 - 1532-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Meta-Analysis; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0028-4793 
<br/><br/><label>Standard No.: </label>10.1056/NEJM199105303242202  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-Antagonists--therapeutic use<br/>Ascites--complications<br/>Esophageal and Gastric Varices--complications<br/>Female<br/>Gastrointestinal Hemorrhage--mortality<br/>Humans<br/>Liver Cirrhosis--complications<br/>Liver Cirrhosis, Alcoholic--complications<br/>Male<br/>Meta-Analysis as Topic<br/>Middle Aged<br/>Nadolol--therapeutic use<br/>Prognosis<br/>Propranolol--therapeutic use